TP53-DEPENDENT RESISTANCE TOWARDS CHEMOIMMUNOTHERAPY OF B-CELL LYMPHOMA IS MEDIATED BY ALTERED FORMATION OF EXTRACELLULAR VESICLES AND EXOSOMAL PD-L1 EXPRESSION

EHA Library, Elena Izquierdo Álvarez, 293793

GENOMIC ANALYSIS OF DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT.

EHA Library, Joel Wight, 293794

INCORPORATION OF NGS IN CLINICAL PRACTICE IN PATIENTS WITH DLBCL AND FL USING TUMOR AND CTDNA SAMPLES

EHA Library, Bastos Oreiro, 293795

DROPLET DIGITAL PCR FOR NON-INVASIVE MUTATIONAL SCREENING IN WALDENSTRÖM MACROGLOBULINEMIA AND IGM-MGUS: FIRST RESULTS OF THE FONDAZIONE ITALIANA LINFOMI (FIL) BIO-WM TRIAL

EHA Library, Simone Ferrero, 293796

INCREASING ANTIBODY-DEPENDENT LYMPHOMA CELL CLEARANCE BY MACROPHAGESTHROUGH INHIBITION OF THE PENTOSE-PHOSPHATE-PATHWAY

EHA Library, Anna Beielstein, 293797

SINGLE-CELL IMMUNE PROFILING PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN'S LYMPHOMA (NHL) TREATED WITH IBRUTINIB (IBR) + NIVOLUMAB (NIVO)

EHA Library, Tatiana Perova, 293798

TARGETING ANTI-APOPTOTIC MCL1 PROTEIN WITH S63845 IS HIGHLY EFFECTIVE IN AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS WITH NON-EXPRESSION OF BCL2

EHA Library, Magdalena Klanova, 293799

UNRAVELING THE LANDSCAPE OF COPY NUMBER ABERRATIONS IN HODGKIN LYMPHOMA: A JOINT KULEUVEN AND LYSA STUDY ON CELL-FREE CIRCULATING DNA

EHA Library, Lieselot Buedts, 293800

DUOHEXABODY®-CD37 SHOWS POTENT ANTI-TUMOR ACTIVITY IN PRE-CLINICAL B-CELL LYMPHOMA MODELS IN VITRO AND IN VIVO

EHA Library, Marije B. Overdijk, 293801

DIFFERENTIAL ACTIVATION OF THE B-CELL RECEPTOR (BCR) SIGNALING PATHWAY BY RITUXIMAB AND OBINUTUZUMAB

EHA Library, Jennifer Edelmann, 293802

HETEROGENEOUS EVOLUTION OF DIFFUSE LARGE B CELL LYMPHOMA UNDER TREATMENT WITH A NEW HDAC INHIBITOR LAQ824 AND THE MECHANISM STUDY OF DRUG RESISTANCE

EHA Library, Hui Jin, 293803

A NOVEL LONG NONCODING RNA ENST00000503502 PROMOTES T CELL LYMPHOMA AGGRESSIVENESS BY ACTIVATING TGF-Β SIGNALING PATHWAY

EHA Library, Ping Zhao, 293804

HIGHLY SPECIFIC CYTOTOXIC EFFECT OF T22-DITOX-H6 NANOPARTICLE IN CXCR4+ DIFFUSE LARGE B-CELL LYMPHOMA CELLS

EHA Library, Aïda Falgàs, 293805

CYTARABINE CONTAINING NANOTHERAPEUTICS FOR EXPERIMENTAL THERAPY OF MANTLE CELL LYMPHOMA

EHA Library, Pavel Klener, 293806

LYNX (LYMPHOID NGS): A VERSATILE NGS PANEL FOR COMPREHENSIVE ANALYSIS OF MOLECULAR MARKERS WITH CLINICAL RELEVANCE IN LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Veronika Navrkalova, 293807

THE C-GAS-STING IMMUNE RESPONSE PATHWAY IS ACTIVATED AND PARTIALLY REGULATED BY SAMHD1 IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ioanna Xagoraris, 293808

CENTRAL ROLE OF MORAXELLA CATARRHALIS RPOC AND MID/HAG IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA

EHA Library, Lorenz Thurner, 293809

EPIGENETIC REGULATION OF HGF/C-MET SIGNALING PATHWAY CONFERS AGGRESSIVENESS IN LYMPH NODE ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Haruhito Totani, 293810

MANTLE CELL LYMPHOMA CELL SURVIVAL RELIES ON HIGH ACTIVITY OF PROTEIN KINASE CK1 ALPHA: IMPLICATIONS FOR BCR INHIBITORS RELATED THERAPY

EHA Library, Sabrina Manni, 293811

OVEREXPRESSION OF PD-1 ON PERIPHERAL T LYMPHOCYTES WAS CORRELATED TO INFLAMMATORY PHENOTYPE OF TUMOR MICROENVIRONMENT AND PREDICTED DISMAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Xiao Li, 293812

CHARACTERIZATION OF ASTX660, AN ANTAGONIST OF CIAP1/2 AND XIAP, IN MOUSE MODELS OF T CELL LYMPHOMA

EHA Library, George Ward, 293813

LNCRNA BCYRN1 MEDIATES L-ASPARAGINASE RESISTANCE THROUGH ENHANCEMENT OF AUTOPHAGY IN NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, Liang Wang, 293814

COMPREHENSIVE ASSESSMENT OF MOLECULAR MARKERS OF SELINEXOR RESPONSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Christopher Walker, 293815

THE EFFICACY OF OBINUTUZUMAB RETREATMENT IN OBINUTUZUMAB-INDUCED DIRECT CELL DEATH RESISTANT CD20-POSITIVE NON-HODGKIN LYMPHOMA MODEL

EHA Library, Takaaki Fujimura, 293816

EVALUATION OF PHARMACODYNAMIC BIOMARKERS OF EPCORITAMAB (GEN3013; CD3XCD20): RESULTS FROM A PHASE 1/2 DOSE-ESCALATION STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Christopher Chiu, 293817

CELL-OF-ORIGIN CLASSIFICATION IN DIFFUSE LARGE B-CELL LYMPHOMAS : PROGNOSIS BY IMMUNOCHEMISTRY (HANS) AND GENE EXPRESSION PROFILING (LST RNA ASSAY NANOSTRING™) IN A FRENCH RETROSPECTIVE COHORT

EHA Library, Gauthier Decool, 293818

NM23-H1: A LEUKAEMIA AND LYMPHOMA DERIVED MESSENGER THAT ALTERS THE TUMOUR MICROENVIRONMENT BY ACTING AS A TUMOUR-ASSOCIATED MOLECULAR PATTERN (TAMP) AND ACTIVATING THE ALTERNATIVE NLRP3 INFLAMMASOME

EHA Library, Sandro Trova, 293819

HIGH THROUGHPUT T CELL RECEPTOR PROFILING IN SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA PROVIDES A NOVEL DEEPER INSIGHT INTO THE CHARACTERISTICS OF THE MALIGNANT POPULATION

EHA Library, Vasileios Bikos, 293820

A NOVEL CIRCULAR RNA 0066971 INHIBIT EPSTEIN BARR VIRUS–POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA AGGRESSIVENESS BY SUPPRESSING RAS SIGNALING PATHWAY

EHA Library, Chenxing Zhao, 293821

EXPRESSION OF THE NOVEL TUMOR SUPPRESSOR SAMHD1 IS AN INDEPENDENT, ADVERSE PROGNOSTIC FACTOR IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ioanna Xagoraris, 293822

EXPLORATION OF MEASURABLE RESIDUAL DISEASE IN STEM CELL PRODUCTS IN MANTLE CELL LYMPHOMA USING NEXT-GENERATION SEQUENCING

EHA Library, Lea A. L. Elkjær, 293823

A TARGETED DRUG SCREEN REVEALS POTENT INHIBITORS OF T-PLL PRIMARY PATIENT CELLS

EHA Library, Sanna Timonen, 293824

THE IRON CHELATOR DEFERASIROX INDUCES APOPTOSIS AND SYNERGIZES WITH IBRUTINIB IN MANTLE CELL LYMPHOMA

EHA Library, Aladin Samara, 293825

TRG CLONALITY INTERROGATION BY CE AND NGS: BRIDGING THE GAP BETWEEN CLASSICAL AND LEADING EDGE TECHNOLOGIES

EHA Library, Kasey Hutt, 293826

WHOLE GENOME ANALYSIS REVEALS POTENTIAL MICRO-RNA'S FOR P53-ASSOCIATED REGULATION OF PDL1 IN B- AND T-CELL LYMPHOMAS

EHA Library, Georgia Kokaraki, 293828

BASELINE AMOUNT OF IMMUNOGLOBULIN M CAN IDENTIFY PATIENTS WITH POOR OUTCOME: RESULTS FROM A REAL-LIFE SINGLE-CENTER STUDY IN HODGKIN LYMPHOMA

EHA Library, Alessandra Romano, 293829

COMBINATION OF TAFASITAMAB (MOR208) AND LENALIDOMIDE ENHANCES TUMOR CELL DEATH OF B-CELL LYMPHOMA IN VITRO

EHA Library, Maria Patra, 293830

THE NPM-ALK ONCOGENIC KINASE ACTIVATES THE C-GAS-STING PATHWAY IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

EHA Library, Jingjing Ye, 293831

MOLECULAR CHARACTERIZATION OF FOXO1 MUTATIONS IN NON-HODGKIN LYMPHOMA

EHA Library, Ariane Sablon, 293832

ANTI-ANGIOGENIC THERAPY WITH BEVACIZUMAB IS EFFECTIVE IN VIVO IN IBRUTINIB-RESISTANT MANTLE CELL LYMPHOMA

EHA Library, Petra Vockova, 293833

TMEM244 GENE IS ECTOPICALLY EXPRESSED IN SÉZARY CELLS DUE TO HYPOMETHYLATION OF ITS PROMOTER

EHA Library, Karolina Rassek, 293834

PD-L1/PD-L2 GENOMIC IMBALANCES IN CLASSICAL HODGKIN LYMPHOMA. ANALYSIS OF BOTH REED-STERNBERG/HODGKIN AND TUMOR MICROENVIRONMENT CELLS. ARGENTINIAN EXPERIENCE.

EHA Library, Mauro García-Montenegro, 293835

PRODUCTS OF EBV-POSITIVE NEOPLASTIC NK-CELLS INDUCE DIFFERENTIATION INTO MACROPHAGES AND PROCOAGULANT ACTIVITY OF MONOCYTES, WHICH LEADS TO HLH

EHA Library, Mayumi Yoshimori, 293836

CYTOKINE EXPRESSION COULD IDENTIFY DIFFERENT PROFILES COMPARING HISTOLOGICAL GRADE IN FOLLICULAR LYMPHOMA. PRELIMINARY RESULTS.

EHA Library, Santiago Mercadal, 293837

LOW PERCENTAGE OF T LYMPHOCYTES IN HODGKIN´S LYMPHOMA LYMPH NODES, MEASURED BY FLOW CYTOMETRY, HAS AN ADVERSE IMPACT ON PROGRESSION FREE SURVIVAL REGARDLESS OF NEGATIVE INTERIM PET SCAN STATUS.

EHA Library, Laura Korin, 293838

PRESENCE OF INNATE LYMPHOID CELLS IN ALLOGENEIC HEMATOPOIETIC CELL GRAFTS CORRELATES WITH REDUCED GRAFT VERSUS HOST DISEASE

EHA Library, Myrddin Verheij, 293839

ENDOTHELIAL MICROPARTICLES-MEDIATED TRANSFER OF LNCRNA NEAT1 PROMOTES THE INITIATION OF ACUTE GVHD AFTER ALLO-HSCT

EHA Library, Ran Zhang, 293840

PLASMATIC EXTRACELLULAR VESICLES AND GRAFT VERSUS HOST DISEASE AFTER POST-TRANSPLANT CYCLOPHOSHAMIDE HAPLOIDENTICAL STEM CELL TRANSPLANTATION.

EHA Library, Benedetto Bruno, 293841

IN VITRO INDUCTION AND EXPANSION OF HUMAN CD4+FOXP3+ REGULATORY T CELLS FROM NAÏVE CD4+ T CELLS

EHA Library, Tzeon-Jye Chiou, 293842

THE STUDY ON BAICALIN REGULATES AUTOPHAGY TO PROTECT THE INTESTINAL MUCOSAL BARRIER TO INTERVENTION OF INTESTINAL AGVHD

EHA Library, Xing Cui, 293843

STRATEGY OPTIMIZATION AND CLINICAL STUDY OF MULTIPLE NUCLEOTIDE POLYMORPHISM ANALYSIS IN THE DETECTION OF CHIMERISM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Zhe Zou, 293844

THE POTENTIAL ROLE OF THROMBOMODULIN GENE POLYMORPHISMS IN THE DEVELOPMENT OF ACUTE GRAFT VERSUS HOST DISEASE AND OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Livia Varga, 293845

CYTOMEGALOVIRUS RESULTS IN POOR GRAFT FUNCTION AFTER ALLO-HSCT VIA BONE MARROW STROMAL CELLS：MSCS AND EPCS

EHA Library, Weiran Lv, 293846

UNRAVELING THE EFFECT OF CD34+MICROPARTICLES FROM CORD BLOOD ON APOPTOSIS OF HEMATOPOIETIC CELLS

EHA Library, FANI DELIGIANNI, 293847

MACHINE LEARNING APPLIED TO GENE EXPRESSION SET ANALYSIS PREDICTS ANTI-APOPTOTIC T-CELLS PROFILE THROUGH SERPINB9 AND CDKN2A IN CGVHD.

EHA Library, Juana Serrano Lopez, 293848

UNEXPECTED VARIABILITY OF DONOR CHIMERISM IN PATIENTS FINGERNAILS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION DETECTED BY DIRECT PCR

EHA Library, Ivana Jeziskova, 293849

LABEL-FREE DEEP LEARNING OF NK CELL SUBTYPES WITH SINGLE-CELL IMAGING FLOW CYTOMETRY DATA

EHA Library, Veera Timonen, 293850

MYELOABLATIVE FRACTIONATED BUSULFAN CONDITIONING REGIMEN IN OLDER PATIENTS: RESULTS OF A PHASE II STUDY

EHA Library, Uday Popat, 293851

IMPACT OF ANTITHYMOCYTE GLOBULIN DOSE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN STEM CELL TRANSPLANTATION FROM UNRELATED DONORS.

EHA Library, Sara Butera, 293852

MESENCHYMAL STROMAL CELLS DECREASE CHRONIC GRAFT-VERSUS-HOST DISEASE IN MICE AND HUMANS THROUGH RESTORING THYMUS

EHA Library, Ke Zhao, 293853

IMPACT OF SPLEEN SIZE AND SPLENECTOMY ON ALLOGENEIC TRANSPLANTATION OUTCOME IN MYELOFIBROSIS: A RETROSPECTIVE ANALYSIS OF 1196 PATIENTS BY THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT

EHA Library, Nicola Polverelli, 293854

CYTOTOXICITY OF DONOR NK CELLS TO ALLOREACTIVE T CELLS AREASSOCIATED WITH ACUTE GVHD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lixia Sheng, 293855

COMPARISON OF HAPLOIDENTICAL BONE MARROW AND UNRELATED PERIPHERAL BLOOD STEM CELL TRANSPLANTATION BOTH WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR ACUTE LEUKEMIA: FROM THE ALWP OF THE EBMT

EHA Library, Arnon Nagler, 293856

SEQUENTIAL EUROFLOW MINIMAL RESIDUAL DISEASE (MRD) MONITORING PREDICTS ALLOGENEIC TRANSPLANT OUTCOME IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Joanne Tan, 293857

IN AML THE CLINICAL VALUE OF THE MEASURABLE RESIDUAL DISEASE STATUS BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION DEPENDS ON THE ASSIGNED ELN RISK GROUP

EHA Library, Madlen Jentzsch, 293858

A GUT MICROBIOTA SCORE PREDICTING FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lijie Han, 293859

THE MYCOBIOME AFTER FMT FOR INTESTINAL GRAFT-VERSUS-HOST DISEASE

EHA Library, Yannouck van Lier, 293860

MANAGEMENT OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA RECEIVING ALLOGENEIC HCT: AN INTERNATIONAL SURVEY ON BEHALF OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT

EHA Library, Francesco Onida, 293861

INTERNATIONAL MULTI-CENTRE RETROSPECTIVE ANALYSIS OF OUTCOMES OF THIOTEPA-BASED AUTOLOGOUS STEM CELL TRANSPLANTATION FOR SECONDARY CNS LYMPHOMA

EHA Library, Jahanzaib Khwaja, 293862

DEFIBROTIDE TREATMENT FOR VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION: OUTCOMES IN ADULT AND PEDIATRIC PATIENTS FROM AN OBSERVATIONAL REGISTRY STUDY

EHA Library, Mohamad Mohty, 293863

FAVORABLE OUTCOMES AFTER SINGLE CORD BLOOD TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK HEMATOLOGICAL DISEASES: A SINGLE-INSTITUTE RETROSPECTIVE ANALYSIS

EHA Library, Fumiya Wada, 293864

THE 2017 ELN RISK STRATIFICATION FOR ACUTE MYELOID LEUKAEMIA (AML) IS PROGNOSTIC FOR OUTCOMES OF ALLOGENEIC STEM CELL (HSCT).

EHA Library, Yan Beauverd, 293865

KINETICS OF HEMATOLOGIC RECOVERY IN PATIENTS WITH MYELOFIBROSIS UNDERGOING AN ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION: THE ROLE OF PATIENT'S AGE AND IMPACT ON MORTALITY

EHA Library, Gabriele Magliano, 293866

SECOND ALLOGENEIC STEM CELL TRANSPLANTATION WITH HAPLOIDENTICAL GRAFTS FOR POST-TRANSPLANT RELAPSE

EHA Library, Samer Srour, 293867

INTENSIFIED MYELOABLATIVE CONDITIONING AGGRAVATES ACUTE GRAFT-VERSUS-HOST DISEASE VIA INFLUENCING INTESTINAL MICROBIOTA IN ALLO-HSCT RECIPIENTS

EHA Library, Lijie Han, 293868

FIRST YEAR REAL-LIFE EXPERIENCE ON CMV PROPHYLAXIS WITH LETERMOVIR IN HIGH-RISK PATIENTS SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Michele Malagola, 293869

ABATACEPT (CTLA4-IG) COMBINED WITH POST TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) AS ACUTE GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS FOR MATCHED DONOR TRANSPLANTS IN ADULTS WITH LEUKAEMIA AND LYMPHOMA

EHA Library, Amit Patel, 293870

IMPROVED SURVIVAL WITH NON-MYELOABLATIVE ALLOGENEIC TRANSPLANTATION (NMAT) COMPARED TO AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR PATIENTS > 60 YEARS WITH RELAPSED FOLLICULAR LYMPHOMA (FL).

EHA Library, Issa Khouri, 293871

INFLUENCE OF INHERITED AND ACQUIRED HEMATOLOGICAL AND IMMUNOLOGICAL GENE VARIANTS ON RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Zhihui Li, 293872

IBRUTINIB TREATMENT FOR PEDIATRIC CHRONIC GRAFT VERSUS HOST DISEASE: A PROSPECTIVE PHASE 1/2 STUDY

EHA Library, Marco Zecca, 293873

FEATURES OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS REACTIVATION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LEUKEMIAS

EHA Library, Yuhua Ru, 293874

RELAPSE HAS NOT DECREASED OVER TIME IN PATIENTS WITH HIGH-RISK MYELODISPLASTIC SYNDROME UNDERGOING AN ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Alessia Di Giovanni, 293875

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULT PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA: A NORDIC RETROSPECTIVE STUDY

EHA Library, Eileen Wedge, 293876

KYNURENINE METABOLITES AND INTERLEUKIN 18 IN FIBROSING CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Thomas Luft, 293877

A PRO-OXIDANT COMBINATION OF RESVERATROL AND COPPER TO REDUCE POST-TRANSPLANT TOXICITY IN PATIENTS WITH MULTIPLE MYELOMA RECEIVING HIGH DOSE MELPHALAN: RESULTS OF AN EXPLORATORY STUDY (RESCU 001).

EHA Library, Anshul Agarwal, 293878

THE NATURAL HISTORY OF EBV REPLICATION, VIRAL LOAD DYNAMICS AND EBV-RELATED DISEASE FOLLOWING T CELL-DEPLETED ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

EHA Library, Maria A. V. Marzolini, 293879

WILMS' TUMOR GENE 1 EXPRESSION IS AN INDEPENDENT PROGNOSTIC INDICATOR FOR PEDIATRIC ACUTE MYELOID LEUKEMIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Dao-Xing Deng, 293880

POOR GRAFT FUNCTION AFTER UNMANIPULATED HAPLOIDENTICAL SCT WITH POST-TRANSPLANT HIGH DOSE CYCLOPHOSPHAMIDE.

EHA Library, Ignacio Gómez-Centurión, 293881

AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MULTIPLE MYELOMA (MM): DOES THE DOSE OF MELPHALAN MATTER? A SINGLE CENTER ANALYSIS ON 313 CONSECUTIVE PATIENTS.

EHA Library, Annamaria Brioli, 293882

STAGE IV INTESTINAL ACUTE GRAFT VERSUS HOST DISEASE: EXPERIENCE AFTER 1428 ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS

EHA Library, Felipe Peña Muñoz, 293883

HIGH PLASMA VITAMIN E LEVELS ARE ASSOCIATED WITH DECREASED ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lars Klingen Gjærde, 293884

INCIDENCE, RISK FACTORS AND OUTCOMES OF DIFFUSE ALVEOLAR HAEMORRHAGE AFTER HAPLOIDENTICAL ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jin Wu, 293885

PROGNOSTIC IMPACT ON THE DOSAGE OF METHOTREXATE COMBINED WITH TACROLIMUS FOR GRAFT-VERSUS HOST DISEASE PROPHYLAXIS AFTER CORD BLOOD TRANSPLANTATION

EHA Library, Miwa Adachi, 293886

BENDA-BEAM HIGH-DOSE THERAPY PRIOR TO AUTO-SCT IS EFFECTIVE IN RESISTANT/RELAPSED DLBCL: FINAL RESULTS FROM A PHASE II MULTI-INSITITUTIONAL STUDY

EHA Library, Alessandro Isidori, 293887

TWO YEAR FOLLOW UP OF ACUTE COMPLETE SPINAL CORD INJURY PATIENTS RECEIVING AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR STEM CELL THERAPY

EHA Library, Renu Rani, 293888

FEASIBILITY AND EFFICACY OF HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADVANCED STAGE MYCOSIS FUNGOIDES AND SÉZARY SYNDROME: A REPORT OF FIVE CONSECUTIVE CASES

EHA Library, Fabio Serpenti, 293889

EFFICACY OF HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA WITH MODIFIED FC PRECONDITIONING ：A REPORT OF 35 CASES

EHA Library, Ma Liangming, 293890

CLINICAL RELEVANCE OF MYC/BCL2, CELL OF ORIGIN AND CONDITIONING REGIMEN IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT).

EHA Library, Issa Khouri, 293891

NEIHULIZUMAB (ABGN-168H) IN PATIENTS WITH STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST-DIEASE (SR-AGVHD): PRELIMINARY RESULTS OF A PHASE I STUDY

EHA Library, Sameem Abedin, 293892

STAND-BY ANTIBIOTIC TREATMENT VERSUS ANTIBIOTIC PROPHYLAXIS DURING ALLOGENEIC STEM CELL TRANSPLANTATION IS SAFE AND FEASIBLE: A RETROSPECTIVE MONOCENTER ANALYSIS

EHA Library, Rosa Toenges, 293893